Publication:
Modified gold nanoparticles to overcome the chemoresistance to gemcitabine in mutant p53 cancer cells

Simple item page
dc.contributor.affiliationInstituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Faraday 9, Madrid, 28049, Spain; Unidad Asociada al Centro Nacional de Biotecnología (CSIC), Darwin 3, Madrid, 28049, Spainen
dc.contributor.affiliation000000041762408X
dc.contributor.authorGarcía-Garrido E.
dc.contributor.authorCordani M.
dc.contributor.authorSomoza, Álvaro
dc.date.accessioned2022-01-11T09:05:17Z
dc.date.available2022-01-11T09:05:17Z
dc.date.issued2021
dc.format.mimetypeapplication/pdfen
dc.identifier.doi10.3390/pharmaceutics13122067en
dc.identifier.urihttp://hdl.handle.net/20.500.12614/2764
dc.issue.number2067en
dc.journal.titlePharmaceuticsen
dc.language.isoenen
dc.relation.projectIDTEMPThis work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2017-87305-R, PID2020-119352RB-I00), Comunidad de Madrid (IND2017/IND-7809), and IMDEA Nanociencia. IMDEA Nanociencia acknowledges support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686, CEX2020-001039-S).
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen accessen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleModified gold nanoparticles to overcome the chemoresistance to gemcitabine in mutant p53 cancer cellsen
dc.typeresearch articleen
dc.type.hasVersionVoRen
dc.volume.number13en
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Modified-gold-nanoparticles-to-overcome-the-chemoresistance-to-gemcitabine-in-mutant-p53-cancer-cellsPharmaceutics.pdf
Size:
1.95 MB
Format:
Adobe Portable Document Format
Download

Collections

Publications